Scientific Data of Functional
Food
Reports of Recovery from Disease due to
BRM4 - Cases 1-11
Please note that
these reports make reference to
MGN-3.
BRM4
was previously sold under the name of
MGN-3
in the
USA.
| No. 1 Chronic
hepatitis |
| NAME/N.M |
AGE/48 |
SEX/Male |
RESIDENCE/Nagano |
| Clinical Record and Treatment |
| In early March 1996, the
patient felt unusual languidness, and had his chronic hepatitis
(non-viral) and his slight diabetes diagnosed at H
polyclinic.
The patient entered the clinic on May
30th, 1996. After rest and an intravenous injection for
Major Minofargen C, his liver function came to a temporary lull and
he left the clinic after one month.Thereafter, the patient
experienced periodic deterioration in his liver functions in spite
of continuing intravenous treatment for Major Minofargen C, and
suffered from chronic hepatitis until the beginning of March 1997.
The patient then started taking 3g of MGN-3 per day (1g/dose) and
his level of liver function increased to nearly the same level as
at the beginning of therapy 12 days earlier. The level gradually
decreased, reaching the lowest value after one month. The patient's
GOT and GPT levels returned to normal one month later. Presently,
the patient's liver function has returned to normal, and the
patient is experiencing no other health-related
problems.
Changes due to
MGN-3
The patient's energy level increased after MGN-3
administration, and his unusual fatigue (especially in the
afternoon) gradually abated. The patient was able to sleep and wake
normally, had a good appetite, and looked very healthy.
Evaluation
As indicated by the figure below, the GOT and GPT
levels temporarily increased after the administration of MGN-3,
before steadily decreasing and returning to normal. During MGN-3
administration, no special treatments were performed; therefore, it
is possible to conclude that these changes were due to MGN-3. These
results suggest that MGN-3 protected the patient's liver and its
immunopotentiation function was effective.  | |
| No.2 Cirrhosis |
| NAME/K. H. |
AGE/65 |
SEX/Female |
RESIDENCE/Hyogo |
| Clinical Record and Treatment |
| In 1983, the patient was
infected with hepatitis C by a blood transfusion conducted during
an operation for uterine cancer. The patient was not convalescing
satisfactorily and was suffered from cirrhosis of the liver. In
1992, the patient took a dose of interferon, but only suffered
various side effects. At present, some of the cirrhosis symptoms
such as liver cell dysfunction and liver fibrinogenerous have
progressed slightly, but there has been no liver circulatory
trouble thus far. The patient has taken 3g of MGN-3 daily (1g/dose)
since April 1996.
Changes due to
MGN-3
The patient has been able to sleep well since
administration of MGN-3 began. Her appetite has improved and the
patient has been able to evacuate easily. The patient's energy
levels have improved after one week of treatment, and has been able
to remain out of bed for longer periods of time. The patient gets
up between 6:00 and 6:30 in the morning, and often goes out except
when it is time for an intravenous drip, but does not feel
excessively fatigued. Her frequency of urination at night has
decreased.
Evaluation
As seen in the examination results for these two
months, the patient's condition does not warrant any optimism.
However, the patient herself is doing very well and enjoying her
hobbies and volunteer work. Her doctor commented that her
examination results were not necessarily consistent with her health
condition. This suggests that MGN-3 can maintain proper liver
functions and promote IF-γ due to NK cell
activation. |
| |
26/03/97 |
22/04/99 |
| Total
bilirubin |
|
1.3mg/dl |
| GOT |
70 IU/l |
55
IU/l |
| GPT |
72 IU/l |
47
IU/l |
| LDH |
506 IU/l |
404
IU/l |
| γ-GTP |
|
42
IU/l |
| Albumin |
49.8% |
|
| γ-globulin |
33.4% |
| |
| No.3 Liver
cancer |
| NAME/N. K. |
AGE/63 |
SEX/Female |
RESIDENCE/Hyogo |
| Clinical Record and Treatment |
| In 1989, the patient was
diagnosed with liver cancer at a hospital in Hyogo prefecture.
Surgery was impossible due to the rapid spread of the disease. The
patient's condition did not improve despite chemotherapy and
actually worsened, as she also suffered from rhexis of esophageal
varices and liver aneurysm. In August 1996, the patient's condition
became desperate and in September she began taking 3g of MGN-3 per
day. As of June 1997, the patient is receiving treatments based on
holistic medicine at O hospital in Saitama prefecture.
Changes due to
MGN-3
The patient had no success with various folk
remedies and health foods, but got positive results from MGN-3. She
recalls, "I feel an almost mysterious power. It is very hard to
express the feeling, but I felt as if my body and the cancer could
now
co-exist." | |
| No.4 Diabetes |
| NAME/K. M |
AGE/64 |
SEX/Male |
RESIDENCE/Hyogo |
| Clinical Record and Treatment |
| In September
17th, 1993, the patient was diagnosed with
insulin-dependent diabetes mellitus at the City of H Hospital in
Hyogo prefecture. His blood sugar level measured two hours after a
meal was 331 mg/dl and his urea level was 1.0. As a result of the
administration of insulin and a 2-month-hospitalization, his blood
sugar level became normal, falling to 200mg/dl. Thereafter, the
patient's blood sugar level was controlled using insulin. His
urinary sugar level was also detected during administration. His
blood sugar level started increasing again in September 1996, and
finally reached 300 mg/dl in 1997. His urinary sugar level was also
very high. The patient began taking the 2g of MGN-3 per day at
1g/dose. His blood sugar level decreased to 200 mg/dl while his
urinary sugar level was not detected. Since February 1997, his
blood sugar has remained stable between 150mg~180mg and he has not
taken insulin since June 1997.
Changes due to
MGN-3
After administration of MGN-3, the patient's
urinary sugar level was not detected and he does not feel languid
in the afternoon. His asthma has also gradually recovered.
Furthermore, the patient is no longer susceptible to flu in the
winter.
Evaluation
The patient's diabetic condition has gradually
improved and at present his blood sugar level is stable and normal
even without insulin. Although a synergistic relation between the
recovery of diabetes and a dose of MGN-3 has yet to be fully
proven, these results suggest some correlation. In addition,
considering the patient's recovery from asthma and his newfound
resistance against the flu, his immune system seems to have
normalized. The MGN-3 effects in improving the immune system and
its function as a dietary fiber might lead advances in the fight
against diabetes.  | |
| No.5 Prostate
cancer |
| NAME/F. N |
AGE/78 |
SEX/Male |
RESIDENCE/Chiba |
| Clinical Record and Treatment |
| In September 1994, the
patient was diagnosed with prostate cancer diagnosed after
experiencing dysuria and lumbago. The tumor widened from his lumbar
region to his thoracic spine. In October 1994, the patient had an
operation and began chemotherapy until December 1996. The patient
kept taking AHCC at a dose of 2g/day from December 1995 to July
1996, while continuing with chemotherapy. In an examination on June
1996, his osteoncus had decreased to half the size of the original
tumor, and all of his tumors had disappeared by December 1996. A
tissue culture of the focus conducted in January 1997 revealed that
the patient had recovered almost completely from cancer.
Changes due to
MGN-3
Chemotherapy decreased the number of white and
red blood cells, causing anemia. After the chemotherapy was
discontinued, the patient started taking AHCC until the patient
recovered from anemia and could continue chemotherapy. His appetite
improved and the patient did not lose weight. His physical strength
was maintained by taking AHCC and MGN-3, giving his body the energy
to fight against the
cancer. | |
| No.6
Endometriosis |
| NAME/S. K |
AGE/34 |
SEX/Female |
RESIDENCE/Hyogo |
| Clinical Record and Treatment |
| The patient had felt
lumber pain around her abdominal region and heavy lumbago since
June 1996, and the pain worsened as the patient walked bending on
herself. At first, her conditions were caused by constipation at a
hospital. Then the patient had her endometriosis diagnosed at
another hospital. While taking the medical examinations for a
month, the patient did not receive any treatment except the
administration of 3g of MGN-3 daily. As a result of the
examinations, her uterus hypertrophy caused by the endometriosis
pressed the ureter, which in turn placed excess pressure on her
kidneys. Although doctors thought she might require an extirpation
of her uterus, the pain eventually subsided sufficiently to allow
her return to her normal lifestyle without any additional
treatment. As of June 1997, the patient is in extremely good
health.
Changes due to
MGN-3
Five days after administration of MGN-3, the
patient began forgetting her pain. After 1 month, the pain
disappeared completely, as if the patient had never suffered from
the
disease. | |
| No.7 Diabetes |
| NAME/T. T |
AGE/55 |
SEX/Male |
RESIDENCE/Hyogo |
| Clinical Record and Treatment |
| The patient was
diagnosed with insulin-dependent diabetes mellitus in 1994. His
blood sugar level was maintained between 157~160 mg/dl by taking 12
units of insulin per day. After the patient began taking 3g of
MGN-3 per day, the administration of insulin was decreased to 6
units.
Changes due to
MGN-3
On the fifth day after administration of MGN-3
was initiated, the patient fell into a hypoglycemia condition and
insulin administration was reduced to 10 units. On the sixth day,
the patient got hypoglycemia again and the insulin dosage was
reduced to 8 units. The third hypoglycemic condition occurred on
the 25th day, and the insulin dosage was reduced to 6
units. Since then, there has been reoccurrence of the patient's
hypoglycemic condition. The patient feels cured of diabetes and has
declared his life worth living
again. | |
| No.8 Prostate
Cancer |
| NAME/C. J. |
AGE/68 |
SEX/Male |
RESIDENCE/U. S.
A. |
| Clinical Record and Treatment |
In July 1995, the
patient was diagnosed with prostate cancer diagnosed at Drew
University Hospital in California, and began receiving two types of
chemotherapy treatments. These treatments yielded little
improvement, and an examination conducted on August 25, 1995
revealed a Gleason score of 9. There was no significant recovery
despite the chemotherapy, and the patient started taking 3g of
MGN-3 per day in January 1996. In April 1996, the patient had a
cryoprostatectomy, without receiving any hormone therapy. The
patient recovered his ability to ejaculate on November 10, 1996.
His NK activity increased after one year of treatment with MGN-3,
and his tumor marker PSA level shows that the cancer is in full
remission. 
Evaluation
The patient started taking MGN-3 after it was
clear that chemotherapy was not effective. Three months later, due
to the involution of the tumor, it became possible to remove the
tumor through a cryoprostatectomy. The MGN-3 likely contributed to
the restoration of the patient's ability to ejaculate. His NK
activity has been maintained by the administration of MGN-3, and
the results suggest that MGN-3 had a positive influence in
preventing the return of the disease and in inducing the involution
of the
tumor. | |
| No.9 Breast
Cancer |
| NAME/M. L. |
AGE/50 |
SEX/Female |
RESIDENCE/U. S.
A. |
| Clinical Record and Treatment |
On August 3, 1991, a
tumor was found in the patient's left breast during a tissue
examination. The patient started taking 3g of MGN-3 per day as
immunotherapy on September 3, 1992. Subsequently, a CAT scan
performed on March 13, 1993 found no tumor. The patient's right
breast was also normal and healthy, as indicated by a mammography
conducted on January 26, 1995. 
Evaluation
The administration of MGN-3 completely healed the
patient's breast cancer within two years. Her NK cell activity
increased rapidly and remained at a high level during MGN-3
administration. The immunity developed as a result of MGN-3 intake
appeared to heal the patient's breast
cancer. | |
| No.10 Breast
Cancer |
| NAME/C. E. |
AGE/51 |
SEX/Female |
RESIDENCE/U. S.
A. |
| Clinical Record and Treatment |
On December 19, 1994, a
tumor was found in the patient's left breast during a biopsy at
UCLA/Drew university hospital. The patient started taking 3g of
MGN-3 per day (1g/dose) on March 7, 1995. By July 31, 1995 a
mammography revealed no tumors, not even a benign one. By January
1997, no tumor was detected. 
Evaluation
After failing to improve despite Hormonotherapy
and Radiotherapy treatments, the patient took MGN-3 in order to
prevent relapses. NK cell activity has increased since the start of
MGN-3 administration, nearly doubling since administration
began. | |
| No.11 Breast
Cancer |
| NAME/C. E. |
AGE/51 |
SEX/Female |
RESIDENCE/U. S.
A. |
| Clinical Record and Treatment |
On December 19, 1994, a
tumor was found in the patient's left breast following a biopsy at
Drew University Hospital, CA. The patient started hormone therapy
with Tomoxifen on January 20, 1995. The patient ended irradiation
therapy on February 17, 1995 and began receiving 3 g MGN-3 per day
(1g/dose) on March 7, 1995. No tumor, benign or otherwise, was
found after a mammography on July 31, 1995. No tumor was found in
the patient's breast during an examination in January 1997.
Evaluation
After receiving hormone therapy and irradiation
therapy, the patient took MGN-3 in order to prevent the recurrence
of cancer. While taking MGN-3, the patient's NK cell activity has
increased gradually and the patient has been maintaining twice the
level of NK cell activity as first measured. This result is thought
to have helped prevent
recurrence. | |
|
